Endocrinopathy Complications and the Role of Serum Ferritin as a Marker of Endocrinopathy Prediction in Patients with Beta‑Thalassemia Major

Endocrinopathy Complications and the Role of Serum Ferritin as a Marker of Endocrinopathy Prediction in Patients with Beta‑Thalassemia Major


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: توحید جعفری کشکی

کلمات کلیدی: Diabetes, hypocalcemia, Iran, Iron overload, pubertal delay

نشریه: 0 , 8 , 0 , 2018

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله توحید جعفری کشکی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه دانشکده بهداشت
کد مقاله 62580
عنوان فارسی مقاله Endocrinopathy Complications and the Role of Serum Ferritin as a Marker of Endocrinopathy Prediction in Patients with Beta‑Thalassemia Major
عنوان لاتین مقاله Endocrinopathy Complications and the Role of Serum Ferritin as a Marker of Endocrinopathy Prediction in Patients with Beta‑Thalassemia Major
ناشر 4
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق) Advances in Human Biology
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Background: This study aimed to estimate the prevalence of complications and in β‑thalassemia patients, to identify its related risk factors and to determine the optimal thresholds of serum ferritin and disease duration as a predictor of the endocrine disease. Materials and Methods: A total of 140 patients with β‑thalassemia major, 65 (46.4%) male with a mean age of 21.4 ± 7.5 (range 8–39) years were enrolled in this study. Logistic regression and receiver operating characteristic curve were used to estimate the diagnostic power of ferritin level and determine the optimal cut points. Results: The serum ferritin level was 3395 ± 2611 µg/L with stable trend across the last 5 years. Puberty delay was the most common complication with the prevalence of 33.6%. There was a significant association between ferritin levels and hypocalcaemia (odds ratio [OR] = 1.29, P = 0.001), short stature (OR = 1.04, P < 0.001) and puberty delay (OR = 1.02, P = 0.002). A >2100 µg/L and >3400 µg/L optimal cut‑off values of serum ferritin level for puberty delay was 2100 area under the curve (AUC = 0.78, P = 0.004) and 3400 for short stature (AUC = 0.74, P < 0.0001). Conclusions: Progressive deterioration of endocrine dysfunction and inadequacy of chelation therapy in older patients are endocrine complications amongst beta‑thalassemia major patients that need more attention. Prosperous control of the ferritin levels before puberty with deferoxamine appeared to be an effective treatment to prevent and reduce diabetes and hypothyroidism. The serum ferritin >1500 µg/L along with early second decade of illness is the best predictor for the development the endocrinopathy.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
توحید جعفری کشکیدوم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
AdvHumBiol83169-3755907_102559.pdf1397/07/21546048دانلود
1.doc1397/07/21236544دانلود
Capture.PNG1397/07/2237394دانلود